09-10-2020 19:00 via medpagetoday.com

FDA Panel: Some Risk OK for Olanzapine Combo With Less Weight Gain

(MedPage Today) -- An FDA advisory committee agreed, albeit with some dissent, that a combination of olanzapine and samidorphan for treating schizophrenia and bipolar disorder was safe as long as it comes with appropriate labeling.
In a 11-6 vote...
Read more »